DeepMed Research

UNIVERSITY OF MISSOURI-COLUMBIA

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Propranolol in Primary Progressive Aphasia

Early Phase 1

Recruiting

Conditions: Aphasia, Primary Progressive

Interventions: Drug: Propranolol
Device: Magnetic Resonance Imaging (MRI)
Drug: Placebo

First Posted Date: 2023-10-04

Last Posted Date: 2025-03-28

Lead Sponsor: University of Missouri-Columbia

Target Recruit Count: 30

Registration Number: NCT06066710

Locations: 🇺🇸
University of Missouri-Columbia, Columbia, Missouri, United States

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis

Not Applicable

Recruiting

Conditions: Generalized Myasthenia Gravis

Interventions: Device: Whole-body Electrical Muscle Stimulation Exercise

First Posted Date: 2023-10-03

Last Posted Date: 2025-04-10

Lead Sponsor: University of Missouri-Columbia

Target Recruit Count: 16

Registration Number: NCT06064695

Locations: 🇺🇸
University of Kansas Clinical Research Center, Fairway, Kansas, United States
🇺🇸
NextGen Precision Health Building, Clinical and Translational Science Unit, Columbia, Missouri, United States

Variability in Microbial Response to Dietary Fiber

Not Applicable

Completed

Conditions: Microbial Colonization

Interventions: Dietary Supplement: High fiber

First Posted Date: 2023-09-05

Last Posted Date: 2024-07-24

Lead Sponsor: University of Missouri-Columbia

Target Recruit Count: 30

Registration Number: NCT06023940

Locations: 🇺🇸
University of Missouri, Columbia, Missouri, United States

Exercise Training and Insulin Sensitivity

Not Applicable

Withdrawn

Conditions: Exercise
Obesity

Interventions: Behavioral: exercise

First Posted Date: 2023-07-05

Last Posted Date: 2024-10-01

Lead Sponsor: University of Missouri-Columbia

Target Recruit Count: 24

Registration Number: NCT05930834

Locations: 🇺🇸
University of Misouri, Columbia, Missouri, United States

Sex-specific Effect of Restricted Sleep on Brain Health

Not Applicable

Recruiting

Conditions: Cerebrovascular Circulation

Interventions: Diagnostic Test: Cerebral blood flow

First Posted Date: 2023-06-27

Last Posted Date: 2024-05-13

Lead Sponsor: University of Missouri-Columbia

Target Recruit Count: 20

Registration Number: NCT05920759

Locations: 🇺🇸
University of Missouri, Columbia, Missouri, United States

NAC Treatment and Outcomes in Patients With Advanced Atherosclerosis and DM

Phase 1

Withdrawn

Conditions: Atherosclerosis of Artery
Peripheral Artery Disease
Diabetes Mellitus
Inflammation
Oxidative Stress

Interventions: Drug: Placebo
Drug: N-acetylcysteine

First Posted Date: 2023-06-18

Last Posted Date: 2023-06-18

Lead Sponsor: University of Missouri-Columbia

Registration Number: NCT05908513

Locations: 🇨🇳
The Second Xiangya Hospital of Central South University, Changsha, Hunan, China
🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China

Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery

Phase 4

Conditions: Spine Surgery
Reversal of Neuromuscular Blockade
Urinary Retention Postoperative

Interventions: Drug: Sugammadex
Drug: Neostigmine
Drug: Rocuronium
Drug: Glycopyrrolate

First Posted Date: 2023-06-02

Last Posted Date: 2023-09-29

Lead Sponsor: University of Missouri-Columbia

Target Recruit Count: 118

Registration Number: NCT05887375

Locations: 🇺🇸
University Hospital, Columbia, Missouri, United States

Feasibility Trial of an Online Course (eMB) to Reduce Anxiety and Depression for Pregnant Women and Their Partners

Not Applicable

Completed

Conditions: Depression
Anxiety Disorders Generalized

Interventions: Behavioral: Online Mothers and Babies Course (eMB)

First Posted Date: 2023-05-22

Last Posted Date: 2023-05-22

Lead Sponsor: University of Missouri-Columbia

Target Recruit Count: 60

Registration Number: NCT05867680

Locations: 🇺🇸
University of Missouri, Columbia, Missouri, United States

Effect of Drain Care on Infection Rate and Quality of Life in Implant-Based Breast Reconstruction.

Not Applicable

Recruiting

Conditions: Quality of Life
Infections

Interventions: Other: Showering 48 hours after surgery

First Posted Date: 2023-05-06

Last Posted Date: 2024-05-30

Lead Sponsor: University of Missouri-Columbia

Target Recruit Count: 100

Registration Number: NCT05846438

Locations: 🇺🇸
University of Missouri, Columbia, Missouri, United States

CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)

Phase 4

Recruiting

Conditions: Cat Bite
Anti-bacterial Agents
Hand Injuries
Arm Injury
Infection, Bacterial

Interventions: Drug: Amoxicillin/clavulanate
Other: Placebo (microcrystalline cellulose)
Procedure: Wound management
Drug: Ciprofloxacin
Drug: Clindamycin

First Posted Date: 2023-05-06

Last Posted Date: 2024-10-01

Lead Sponsor: University of Missouri-Columbia

Target Recruit Count: 72

Registration Number: NCT05846399

Locations: 🇺🇸
University of Missouri, Columbia, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy